CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Share Capital	Additional paid-in capital	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2023		298,502,334
Beginning balance at Dec. 31, 2023	$ 345,296	$ 489,270	$ 19,311	$ (163,285)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issued from financing activities (in shares)		13,064,204
Issued from financing activities	17,436	$ 17,436
Issuance of common shares related to contingent payments (in shares)		2,727,336
Issuance of common shares related to contingent payments	3,564	$ 3,564
Issued on exercise of warrants and stock options (in shares)		594,800
Issued on exercise of stock options	586	$ 1,269	(683)
Share-based compensation	355		355
Share issue costs	(380)	$ (380)
Net loss	(19,700)			(19,700)
Ending balance (in shares) at Mar. 31, 2024		314,888,674
Ending balance at Mar. 31, 2024	$ 347,157	$ 511,159	18,983	(182,985)
Beginning balance (in shares) at Dec. 31, 2024	409,786,956	409,786,956
Beginning balance at Dec. 31, 2024	$ 340,664	$ 606,505	18,977	(284,818)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issued from financing activities (in shares)		33,551,854
Issued from financing activities	18,731	$ 18,731
Issued on exercise of warrants and stock options (in shares)		20,000
Issued on exercise of stock options	9	$ 52	(43)
Share-based compensation	49		49
Share issue costs	(290)	$ (290)
Net loss	$ (41,205)			(41,205)
Ending balance (in shares) at Mar. 31, 2025	443,358,810	443,358,810
Ending balance at Mar. 31, 2025	$ 317,958	$ 624,998	$ 18,983	$ (326,023)